321 related articles for article (PubMed ID: 30268888)
21. Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C.
Mahmood S; Kawanaka M; Kamei A; Izumi A; Nakata K; Niiyama G; Ikeda H; Hanano S; Suehiro M; Togawa K; Yamada G
Antioxid Redox Signal; 2004 Feb; 6(1):19-24. PubMed ID: 14713333
[TBL] [Abstract][Full Text] [Related]
22. Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.
Doi H; Iyer TK; Carpenter E; Li H; Chang KM; Vonderheide RH; Kaplan DE
Hepatology; 2012 Mar; 55(3):709-19. PubMed ID: 21932384
[TBL] [Abstract][Full Text] [Related]
23. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.
Virzì A; Roca Suarez AA; Baumert TF; Lupberger J
Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501266
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of hcv in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR.
Rullier A; Trimoulet P; Urbaniak R; Winnock M; Zauli D; Ballardini G; Rosenbaum J; Balabaud C; Bioulac-Sage P; Le Bail B
Mod Pathol; 2001 May; 14(5):496-505. PubMed ID: 11353061
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
Khatun M; Ray RB
Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
[TBL] [Abstract][Full Text] [Related]
26. The role of iron in hepatic inflammation and hepatocellular carcinoma.
Miyanishi K; Tanaka S; Sakamoto H; Kato J
Free Radic Biol Med; 2019 Mar; 133():200-205. PubMed ID: 30017991
[TBL] [Abstract][Full Text] [Related]
27. Lipid metabolism and liver disease in hepatitis C viral infection.
Koike K; Tsutsumi T; Yotsuyanagi H; Moriya K
Oncology; 2010 Jul; 78 Suppl 1():24-30. PubMed ID: 20616580
[TBL] [Abstract][Full Text] [Related]
28. Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithm.
Zhu L; Chen X; Kong X; Cai YD
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2756-68. PubMed ID: 27208424
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Meringer H; Shibolet O; Deutsch L
World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis C, EGFR, cirrhosis and netrin-1: potential implications for HCC onset].
Plissonnier ML; Lahlali T; Mehlen P; Parent R
Med Sci (Paris); 2016; 32(6-7):566-8. PubMed ID: 27406760
[No Abstract] [Full Text] [Related]
32. Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection.
Xiang T; Yang G; Liu X; Zhou Y; Fu Z; Lu F; Gu J; Taniguchi N; Tan Z; Chen X; Xie Y; Guan F; Zhang XL
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1036-1045. PubMed ID: 28229927
[TBL] [Abstract][Full Text] [Related]
33. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis in hepatitis C virus infection.
Bantel H; Schulze-Osthoff K
Cell Death Differ; 2003 Jan; 10 Suppl 1():S48-58. PubMed ID: 12655346
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.
Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M
Cells; 2019 Nov; 8(11):. PubMed ID: 31694343
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and prevention of hepatocellular carcinoma in HCV infection.
Benvegnù L; Alberti A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):49S-55S. PubMed ID: 9011476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
